- Stephens has initiated coverage on 908 Devices Inc MASS with an Overweight rating and a price target of $14.
- The analyst notes the company has healthy gross margins in the mid-50%s, with the potential for this to move toward ~60% over time.
- Since going public in 2021, 908 has invested heavily in its commercial efforts, including growing its salesforce to ~80 from ~30.
- In addition, the company has invested in R&D, thus resulting in negative EBITDA. Stephens notes that this remains the case in the near term, but over the long term, operating leverage should result in a path to profitability.
- 908 is burning ~$30 million of cash in 2023, declining over time, so MASS is well positioned from a balance sheet perspective to support organic efforts over the coming years.
- The analyst says investors need to be paying more attention. The near-term environment is tricky, so investors likely have some time. Net-net, 908, is well-positioned in rapidly growing end markets, and the industry is moving in its direction, says Stephen analyst.
- Price Action: MASS shares are up 3.21% at $10.29 on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in